Skip to main content
logo
Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
16.67
+0.44 (2.71%)
Sep 2, 2026, 9:52 AM EDT - Market open

AAPG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,5062,4711,812995851932
Market Cap Growth
-61.49%36.38%82.10%16.89%-8.64%-15.02%
Enterprise Value
1,5372,4801,8961,009830798
Last Close Price
16.2326.24----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.9230.1013.4831.7827.99212.05
PB Ratio
18.0812.9548.2399.8714.364.79
P/TBV Ratio
20.7014.0180.87-19.595.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
16.2430.2114.1132.2427.31181.70

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
3.701.486.0925.424.390.88
Net Debt / Equity Ratio
0.35-0.371.479.840.71-0.54
Net Debt / EBITDA Ratio
-0.150.43-1.34-0.85-0.340.73
Net Debt / FCF Ratio
-0.150.41-2.96-0.90-0.340.64
Asset Turnover
0.200.170.380.080.070.01
Inventory Turnover
1.072.782.562.383.29-
Quick Ratio
1.091.691.171.351.785.05
Current Ratio
1.221.791.261.441.865.22
Return on Equity (ROE)
-236.63%-154.56%-235.32%-386.28%-107.45%-75.18%
Return on Assets (ROA)
-28.04%-23.02%-9.25%-20.92%-19.14%-24.97%
Return on Capital Employed (ROCE)
-103.90%-52.20%-26.10%-57.00%-45.30%-36.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-14.36%-7.19%-3.07%-13.12%-15.04%-13.22%
FCF Yield
-13.26%-6.95%-1.03%-10.95%-14.60%-17.57%
Buyback Yield / Dilution
-13.76%-17.90%-7.00%-7.07%-3.56%-17.93%
SEC Filings: 10-K · 10-Q